tiprankstipranks
Poly Medicure Limited (IN:POLYMED)
:POLYMED
India Market
Want to see IN:POLYMED full AI Analyst Report?

Poly Medicure Limited (POLYMED) Price & Analysis

3 Followers

POLYMED Stock Chart & Stats

₹1723.55
-₹86.35(-3.04%)
At close: 4:00 PM EST
₹1723.55
-₹86.35(-3.04%)

Bulls Say, Bears Say

Bulls Say
Multi‑year Revenue ScalingSustained top‑line scaling over multiple years indicates durable market penetration and repeat demand for core consumables. Larger scale supports production leveraging, fixed‑cost absorption and reinvestment into capacity, enabling continued share gains in hospitals and export channels.
Recurring, Volume‑Driven Business ModelSelling routine disposable medical products ties revenue to hospital throughput and procedural volumes, creating predictable, repeat demand. A broad product portfolio enables cross‑selling across departments, stabilizing cash flows and supporting long‑term growth even in modest market expansion scenarios.
Conservative LeverageLow historical leverage provides financial resilience, preserving capacity to fund capex, regulatory approvals and market expansion without large interest stress. A stronger balance sheet improves ability to absorb demand shocks and pursue selective reinvestment or M&A when strategic opportunities arise.
Bears Say
Weak Free Cash FlowPersistent negative free cash flow despite accounting profits signals working‑capital strain or heavy reinvestment, reducing financial flexibility. Over months this constrains dividend capacity, capital allocation options and raises reliance on external financing during growth or unexpected shocks.
Operating Profitability VolatilityA material decline in EBIT while revenue grows suggests margin pressure from input costs, pricing or one‑off items. If operating profitability remains volatile, incremental revenue may not translate into durable cash flows, undermining return on invested capital and the economics of scale.
Rising Absolute DebtAn abrupt rise in total debt—even if leverage stays moderate—heightens refinancing and interest risks, especially with weak free cash flow. Continued debt growth would erode optionality for capex or M&A and could pressure margins if operational cash conversion does not improve.

Poly Medicure Limited News

POLYMED FAQ

What was Poly Medicure Limited’s price range in the past 12 months?
Poly Medicure Limited lowest stock price was ₹1184.00 and its highest was ₹2272.20 in the past 12 months.
    What is Poly Medicure Limited’s market cap?
    Poly Medicure Limited’s market cap is ₹170.29B.
      When is Poly Medicure Limited’s upcoming earnings report date?
      Poly Medicure Limited’s upcoming earnings report date is Jul 29, 2026 which is in 24 days.
        How were Poly Medicure Limited’s earnings last quarter?
        Poly Medicure Limited released its earnings results on May 25, 2026. The company reported ₹6.5 earnings per share for the quarter, missing the consensus estimate of ₹8.175 by -₹1.675.
          Is Poly Medicure Limited overvalued?
          According to Wall Street analysts Poly Medicure Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Poly Medicure Limited pay dividends?
            Poly Medicure Limited pays a Annually dividend of ₹3.5 which represents an annual dividend yield of 0.19%. See more information on Poly Medicure Limited dividends here
              What is Poly Medicure Limited’s EPS estimate?
              Poly Medicure Limited’s EPS estimate is 6.5.
                How many shares outstanding does Poly Medicure Limited have?
                Poly Medicure Limited has 101,359,490 shares outstanding.
                  What happened to Poly Medicure Limited’s price movement after its last earnings report?
                  Poly Medicure Limited reported an EPS of ₹6.5 in its last earnings report, missing expectations of ₹8.175. Following the earnings report the stock price went down -3.778%.
                    Which hedge fund is a major shareholder of Poly Medicure Limited?
                    Currently, no hedge funds are holding shares in IN:POLYMED
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      Company Description

                      Poly Medicure Limited

                      Poly Medicure Limited (PML) specializes in the production and distribution of a wide array of medical devices. Its extensive product portfolio encompasses a comprehensive range of infusion equipment, including IV cannulas, midline and arterial catheters, three-way stopcocks, various infusion sets (standard, safety winged, and measured volume), manifolds, extension lines, stylets/mandrins with luer locks, vial access spikes, central venous catheters, CVP manometers, needle-free connectors, pre-filled syringes, vascular access devices, and blood administration sets. The company also supplies diverse feeding solutions, such as nasogastric, infant, and gastro-duodenal feeding tubes, alongside umbilical catheters. Urology offerings include urine collection bags (with or without measured volume meters), Foley balloon catheters, irrigation sets, and general urine drainage catheters. For respiratory and anesthesia care, PML manufactures endotracheal tubes, tracheostomy tubes, mucus extractors, ventilator and Bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. The company also provides oncology-specific products. Oxygen and respiratory therapy devices feature endobronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oropharyngeal airways, and various oxygen masks, including variable concentration, reservoir, fixed concentration, and aerosol therapy types. Its renal care segment comprises dialyzers, blood lines, complete dialysis systems, fistula needles, hemodialysis catheters, and peritoneal dialysis and transfusion sets. Surgical drainage products include closed wound suction units, underwater seal drainage systems, high-pressure vacuum bottles, Yankauer suction sets, and thoracic drainage catheters. For phlebotomy and blood diagnostics, PML supplies blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors. Blood bag systems are also available. Personal protective equipment (PPE) such as face shields and polymasks, along with viral transport medium kits, form part of its offering. Further miscellaneous medical disposables encompass insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, and universal caps. Established in 1995, the company is headquartered in New Delhi, India.

                      Poly Medicure Limited (POLYMED) Earnings & Revenues

                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Opto Circuits (India) Limited
                      Viyash Scientific
                      Shaily Engineering Plastics Limited
                      Tarsons Products Limited
                      Fischer Medical Ventures Ltd
                      Popular Stocks